|
2025
|
G/S
|
Pharmaceutical products for the treatment of cancer |
|
|
Invention
|
Methods of treating urothelial carcinoma with a pd-1 axis binding antagonist and an rna vaccine. ... |
|
|
Invention
|
Rna encoding an immune inhibitory il-1 family member. The present invention provides an isolated ... |
|
2024
|
Invention
|
Anti-ctla-4 antibody for treatment of patients with prostate cancer and combination therapy with ... |
|
|
Invention
|
Cfc1 binding molecule. The present invention relates to a binding molecule comprising a CFC1 bind... |
|
|
Invention
|
Anti-bacterial polypeptides. The present disclosure relates to mutated polypeptides comprising a ... |
|
|
Invention
|
Method and kit for measuring and reducing protein impurities. The present invention relates to a ... |
|
|
Invention
|
Compositions comprising an endolysin and uses thereof. The present invention relates to new pharm... |
|
|
Invention
|
Handsfree documentation of pharmaceutical operations using an extended reality device. Documentat... |
|
|
Invention
|
Antibodies capable of binding to ox40 in combination therapy. The present invention provides comb... |
|
|
Invention
|
Sars-cov-2 immunogenic compositions. Disclosed herein are compositions comprising protein antigen... |
|
|
Invention
|
Coronavirus vaccine. This disclosure relates to the field of RNA to prevent or treat coronavirus ... |
|
|
Invention
|
Co-delivery system. The present invention relates to a co-delivery system comprising one or more ... |
|
|
Invention
|
Compositions and methods for preparing vaccines. ex vivo in vitroin vitro. The present disclosure... |
|
|
Invention
|
Particles, compositions and methods. The present disclosure relates generally to functionalized p... |
|
|
Invention
|
Antibody-drug conjugates having a tailor-made drug-to-antibody ratio. The present invention provi... |
|
|
Invention
|
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy.
The pr... |
|
|
Invention
|
Multispecific t cell engagers compositions and methods of use thereof. Compositions and methods f... |
|
|
Invention
|
Agents and methods for targeted delivery of immune effector cells. The invention relates to agent... |
|
|
Invention
|
Formulation for administration of rna.
The present invention relates to compositions comprising ... |
|
|
Invention
|
Tnf receptor 2-specific agonist fusion proteins comprising tnf homology domains and mutated fc do... |
|
|
Invention
|
Rna constructs with n-terminal degrons to enhance an immune response. The present disclosure rela... |
|
|
Invention
|
Method. nnn RNA molecule species, wherein n is an integer of at least 1, or (d) the potency of a ... |
|
|
Invention
|
Nucleic acid compositions and methods. The present invention provides nucleic acid compositions a... |
|
|
Invention
|
Antibody-drug conjugate. The present invention relates to an antibody-drug conjugate of formula (... |
|
|
Invention
|
Coronavirus vaccine.
This disclosure relates to the field of RNA to prevent or treat coronavirus... |
|
|
Invention
|
Preparation and storage of liposomal rna formulations suitable for therapy.
The present disclosu... |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical preparations; vaccines. |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
G/S
|
Downloadable computer software used for biotechnology research and development; downloadable comp... |
|
|
G/S
|
Database management; data management; data processing; data management services; compilation of d... |
|
|
G/S
|
Computer software; computer software comprising algorithms for the selection of pharmaceutical re... |
|
|
G/S
|
Databases; database engines; data processing software; data management software; data mining soft... |
|
|
Invention
|
Antibody-drug conjugate. The present invention relates to an antibody-drug conjugate that compris... |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
G/S
|
Pharmaceuticals; vaccines. |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer |
|
2023
|
Invention
|
Glycolipid compositions. Provided herein are particles and compositions comprising one or more gl... |
|
|
G/S
|
Chemical products for medical and veterinary purposes;
medical and pharmaceutical preparations. ... |
|
|
G/S
|
Chemical preparations for medical and veterinary purposes, namely, for neuroregeneration and the ... |
|
|
Invention
|
Antigen binding proteins specifically binding to cd3 and their use in medicine. The present inven... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and... |
|
|
Invention
|
Methods of treatment using agents binding to epcam and cd137 in combination with pd-1 axis bindin... |
|
|
Invention
|
Rna compositions for delivery of incretin agents. The present disclosure provides compositions (e... |
|
|
Invention
|
Methods and compositions for localized expression of administered rna. Disclosed herein are metho... |
|
|
Invention
|
Nucleic acid compositions comprising a multivalent anion, such as an inorganic polyphosphate, and... |
|
|
G/S
|
Pharmaceutical products for treatment of cancer |
|
|
Invention
|
Novel therapeutic uses of gardnerella endolysins.
The present invention relates to new therapeut... |
|
|
Invention
|
Cyclic epitope tags.
The present invention relates to cyclic peptides useful as epitope tags, an... |
|
|
Invention
|
Analysis of rna molecules using catalytic nucleic acids.
The present invention relates to a meth... |
|
2022
|
Invention
|
Lipid-based formulations for administration of rna.
The present disclosure relates to compositio... |
|
|
Invention
|
Rna constructs and uses thereof.
Disclosed herein are RNA polynucleotides comprising a 5′ Cap, a... |
|
|
G/S
|
Personal development by means of training and further training for doctors and scientists in the ... |
|
|
Invention
|
Methods for determining mutations for increasing modified replicable rna function and related com... |
|
|
Invention
|
Modified replicable rna and related compositions and their use.
The present invention relates to... |
|
|
Invention
|
Potency assay for therapeutic potential of coding nucleic acid.
The invention provides potency a... |
|
|
G/S
|
Transportable buildings of metal, namely, modular containers; transportable buildings of metal, n... |
|
|
G/S
|
Transportable buildings of metal; transportable buildings of metal for the manufacture and fillin... |
|
|
G/S
|
Transportable buildings of metal; transportable buildings of
metal for the manufacture and filli... |
|
2021
|
G/S
|
Chemicals for use in pharmaceutical industry;
Active chemical ingredients for use in manufacture... |
|
|
G/S
|
Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture ... |
|
|
Invention
|
Therapeutic rna for hpv-positive cancer.
This disclosure relates to the field of therapeutic RNA... |
